I agree that this site is using cookies. You can find further informations here.
X
Sidhu, Jagdev
26  results:
Search for persons X
?
1

Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concen..:

Zhang, Ying ; Tortorici, Michael A. ; Pawaskar, Dipti...
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  3 - p. 158-165 , 2018
Link: https://doi.org/10.1002/..
 
?
2

Population pharmacokinetics of subcutaneous C1‐inhibitor fo..:

Pawaskar, Dipti ; Tortorici, Michael A. ; Zuraw, Bruce...
Clinical & Experimental Allergy.  48 (2018)  10 - p. 1325-1332 , 2018
Link: https://doi.org/10.1111/..
 
?
3

Enhancing Patient Flexibility of Subcutaneous Immunoglobuli..:

Sidhu, Jagdev ; Rojavin, Mikhail ; Pfister, Marc.
Biologics in Therapy.  4 (2014)  1-2 - p. 41-55 , 2014
Link: https://doi.org/10.1007/..
 
?
4

Pharmacodynamic Consequences of Administration of VLA-4 Ant..:

Wolf, Christian ; Sidhu, Jagdev ; Otoul, Christian...
PLoS ONE.  8 (2013)  3 - p. e58438 , 2013
Link: https://doi.org/10.1371/..
 
?
5

Pharmacokinetics and tolerability of lamotrigine and olanza..:

Sidhu, Jagdev ; Job, Sarah ; Bullman, Jonathan...
British Journal of Clinical Pharmacology.  61 (2006)  4 - p. 420-426 , 2006
Link: https://doi.org/10.1111/..
 
?
6

The pharmacokinetic and pharmacodynamic consequences of the..:

Sidhu, Jagdev ; Job, Sarah ; Singh, Sunita.
British Journal of Clinical Pharmacology.  61 (2005)  2 - p. 191-199 , 2005
Link: https://doi.org/10.1111/..
 
?
7

Steady-state pharmacokinetics of the enantiomers of citalop..:

Sidhu, Jagdev ; Priskorn, Morten ; Poulsen, Mette...
Chirality.  9 (1997)  7 - p. 686-692 , 1997
Link: https://doi.org/10.1002/..
 
?
8

Low IgG Trough Levels at the End of 4 Week Treatment Cycle ..:

Berger, Melvin ; Hubsch, Alphonse P. ; Sidhu, Jagdev S..
Journal of Allergy and Clinical Immunology.  135 (2015)  2 - p. AB96 , 2015
Link: https://doi.org/10.1016/..
 
?
9

Flexible Dosing For Hizentra®: Pharmacokinetic Simulations ..:

Rojavin, Mikhail ; Sidhu, Jagdev S. ; Bexon, Martin.
Journal of Allergy and Clinical Immunology.  133 (2014)  2 - p. AB182 , 2014
Link: https://doi.org/10.1016/..
 
?
10

Pharmacokinetic Modeling Predicts Different IgG Exposures U..:

Sidhu, Jagdev S. ; Rojavin, Mikhail ; Berger, Melvin..
Journal of Allergy and Clinical Immunology.  133 (2014)  2 - p. AB181 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Biweekly Administration of Subcutaneous Immunoglobulin: Pre..:

Sidhu, Jagdev S. ; Bexon, Martin ; Rojavin, Mikhail..
Journal of Allergy and Clinical Immunology.  131 (2013)  2 - p. AB185 , 2013
Link: https://doi.org/10.1016/..
 
?
12

Switching From Monthly Intravenous to Biweekly Subcutaneous..:

Rojavin, Mikhail ; Landersdorfer, Cornelia ; Bexon, Martin..
Journal of Allergy and Clinical Immunology.  131 (2013)  2 - p. AB109 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Individuals, Subgroups or Cohorts? A Population Pharmacokin..:

Bexon, Martin ; Edelman, Jonathan M. ; Rojavin, Mikhail...
Journal of Allergy and Clinical Immunology.  131 (2013)  2 - p. AB227 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Gentamicin Dosing in Elderly Patients Based on Bioelectrica..:

Sidhu, Jagdev S. ; Triggs, Edward J. ; Charles, Bruce G..
Therapeutic Drug Monitoring.  16 (1994)  4 - p. 352-360 , 1994
Link: https://doi.org/10.1097/..
 
?
15

Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concen..:

Zhang, Ying ; Tortorici, Michael A ; Pawaskar, Dipti...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869560/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15